FDA Circular No. ____ Subject: Guidelines on the Classification of Deficiencies Observed During Inspection of the Conduct of Clinical Trials; (4 page(s), in English)
FDA Circular No. ____ Subject: Guidelines on the Classification of Deficiencies Observed During Inspection of the Conduct of Clinical Trials; (4 page(s), in English)